Log in

WOK WORK Medical Technology Group LTD NASDAQ · United States

WORK Medical Technology Group LTD (WOK) news

WORK Medical Technology Group LTD is a public biotech or pharmaceutical company listed on NASDAQ under the ticker WOK, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest WORK Medical Technology Group LTD news

We have not published a story on WORK Medical Technology Group LTD yet. When there is news, it will appear here.

WORK Medical Technology Group LTD annual financials

LineFY ended Sep 30, 2025FY ended Sep 30, 2024
Research and development$435,311$302,511
Net income (loss)-$1.1 million-$3.5 million
Cash from operations$6.2 million-$2.2 million
Cash and equivalents$4.1 million$6.6 million

Latest balance sheet, Sep 30, 2025 (20-F): cash and equivalents $4.1 million.

Figures as reported to the SEC in XBRL; each one links to its filing. Not adjusted, not investment advice.

Questions about WORK Medical Technology Group LTD

What is the ticker symbol of WORK Medical Technology Group LTD?

WORK Medical Technology Group LTD trades under the ticker WOK on NASDAQ.

Where is WORK Medical Technology Group LTD listed?

WORK Medical Technology Group LTD is listed on NASDAQ.

Which country or territory is WORK Medical Technology Group LTD listed under?

Our directory records WORK Medical Technology Group LTD under United States.

Does aibio.space cover WORK Medical Technology Group LTD?

aibio.space lists WORK Medical Technology Group LTD among 2,820 public biotech companies and publishes its news here as stories appear.

Is WORK Medical Technology Group LTD profitable?

WORK Medical Technology Group LTD reported a net loss of $1.1 million for the fiscal year ended Sep 30, 2025, and generated $6.2 million of cash from operations, per its annual report to the SEC.

How much does WORK Medical Technology Group LTD spend on research and development?

$435,311 in the fiscal year ended Sep 30, 2025, per its annual report.

How much cash does WORK Medical Technology Group LTD have?

$4.1 million in cash at Sep 30, 2025, per its 20-F.

Investor discussion: WORK Medical Technology Group LTD

Members talk about WORK Medical Technology Group LTD (WOK). Reader posts, not aibio.space reporting, and not investment advice.

Rules
  1. Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
  2. Say whether you hold the stock. Every post states long, short or no position.
  3. No paid or sponsored posts. Do not post for anyone who pays or rewards you.
  4. No buy or sell calls and no price targets.
  5. No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
  6. No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Capital-markets timeline

Financings, listing notices, splits, legal actions and other investor events at WORK Medical Technology Group LTD, newest first. Each line links the filing it comes from.

  1. Listings

    Reported a notice from its stock exchange about continued listing requirements. SEC Form 6-K. Source

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open NASDAQ:WOK on TradingView.

Listing details

WORK Medical Technology Group LTD is a public biotech or pharmaceutical company listed on NASDAQ under the ticker WOK, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Company
WORK Medical Technology Group LTD
Ticker
WOK
Listing
NASDAQ
Country or territory
United States

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction

Full desks

Every other company has a starter desk. Search above to open one.

Settings

Appearance
Text size
Motion

Stops the news strip and the share rollers.

Your choices are saved in this browser only.

Free membership

Read aibio.space in full, free

Subscribe with your email address to read every story, company desk and profile in full. It costs nothing. In return, you agree that we may email you, including offers. One click to unsubscribe.

No card, no password. With email, we send one message to confirm your address first. With Google or Facebook we receive only your email address. Not investment advice.